Antidepressant and Antipsychotic Choice for Cyclic Vomiting Syndrome
For prophylactic management of moderate-to-severe cyclic vomiting syndrome in adults, amitriptyline (a tricyclic antidepressant) is the first-line medication, starting at 25 mg nightly and titrating to a goal dose of 75-150 mg. 1
Antidepressant Recommendations
First-Line: Tricyclic Antidepressants (TCAs)
The 2024 AGA Clinical Practice Update and 2019 ANMS-CVSA guidelines both strongly recommend TCAs as first-line prophylactic therapy for moderate-to-severe CVS 1, 2. The specific TCAs recommended include:
- Amitriptyline (preferred)
- Nortriptyline (alternative TCA)
- Doxepin (alternative TCA)
Dosing strategy for TCAs:
- Start at 25 mg at bedtime
- Titrate slowly by 10-25 mg increments every 2 weeks
- Goal dose: 75-150 mg nightly (or 1-1.5 mg/kg) 1
- Recent real-world data shows many patients respond to lower doses, with mean effective dose of 26.5 mg 3
Key considerations:
- Slow titration improves tolerability
- Amitriptyline has more anticholinergic/antihistaminergic activity than nortriptyline
- Common adverse effects: somnolence, dry mouth, blurred vision, constipation, weight gain, prolonged QTc 1
- Baseline ECG is advisable due to QTc prolongation risk
- Dosed at night to leverage sedating properties
When TCAs Are Insufficient
If TCAs alone are inadequate, the treatment algorithm progresses to:
- Second-line: Add an SSRI or SNRI to the TCA 3
- Third-line: Consider topiramate (100-150 mg daily in divided doses) 1, 3
Antipsychotic Recommendations
Limited Evidence for Antipsychotics
The current guidelines do NOT recommend antipsychotics as standard prophylactic therapy for CVS. The evidence base is extremely limited:
- Chlorpromazine is mentioned only for acute episode management (as an antiemetic), not prophylaxis 4
- Risperidone appears in a single 2016 case report of a refractory adolescent who responded to risperidone combined with amitriptyline 4
The literature search on antipsychotics for CVS yielded only 2 relevant articles out of 13 screened, highlighting the paucity of evidence 4. Antipsychotics should be reserved for truly refractory cases that have failed standard prophylactic therapies.
Acute Episode Management (Antiemetics)
For acute episodes, the following dopamine antagonists (which have antipsychotic properties) are used as antiemetics:
Prochlorperazine: 5-10 mg every 6-8 hours or 25 mg suppository every 12 hours 1
- Caution: extrapyramidal symptoms, neuroleptic malignant syndrome (rare)
Promethazine: 12.5-25 mg orally/rectally every 4-6 hours 1
- Caution: tissue injury with peripheral IV administration
These are used for symptom control during episodes, not as prophylaxis.
Critical Treatment Algorithm
Severity-based approach:
- Mild CVS (<4 episodes/year, <2 days each, no ED visits): Abortive therapy only
- Moderate-severe CVS (≥4 episodes/year, >2 days each, requiring ED/hospitalization): Both prophylactic AND abortive therapy 1
Prophylactic medication hierarchy:
- First-line: Amitriptyline (or other TCA)
- Alternate first-line options: Topiramate or aprepitant 2
- Second-line additions: Zonisamide, levetiracetam, or mitochondrial supplements 2
Important Caveats
Substance use significantly impacts treatment response:
- Opioid cessation is associated with improved response to neuromodulators (p=0.03) 3
- Cannabis cessation is also important for treatment success 3
- 33% of CVS patients use opioids and 19% use cannabis at baseline 3
- Screen for and address substance use before declaring treatment failure
Comorbidities requiring attention:
- Anxiety and depression (common in CVS)
- Migraine headaches (strong association)
- Irritable bowel syndrome (associated with 6.59-fold increased odds of opioid use) 3
- Autonomic dysfunction and sleep disorders 2
Common pitfall: Mistaking cannabinoid hyperemesis syndrome (CHS) for CVS. CHS requires prolonged (>1 year) and heavy cannabis use (≥4 times weekly) that precedes symptom onset, and requires 6 months of cannabis cessation to rule out 1.